Baseline characteristics of study subjects by treatment group
Treatment group | ||
---|---|---|
CGM | Control | |
n | 67 | 62 |
Female sex | 36 (54) | 32 (52) |
Age (years) | 29.3 ± 16.3 | 32.0 ± 17.7 |
≥25 | 34 (51) | 33 (53) |
15–24 | 15 (22) | 18 (29) |
8–14 | 18 (27) | 11 (18) |
Race: non-Hispanic white | 63 (94) | 58 (94) |
Duration of diabetes by age-group | ||
≥25 years old | 25.6 ± 16.6 | 28.6 ± 12.7 |
15–24 years old | 8.7 ± 5.3 | 8.1 ± 4.5 |
8–14 years old | 4.9 ± 2.6 | 4.4 ± 3.2 |
Insulin modality | ||
Pump | 62 (93) | 49 (79) |
Multiple daily injections | 5 (7) | 13 (21) |
Total daily dose of insulin by age-group (units/kg) | ||
≥25 years old | 0.5 ± 0.1 | 0.5 ± 0.1 |
15–24 years old | 0.7 ± 0.2 | 0.8 ± 0.2 |
8–14 years old | 0.8 ± 0.1 | 0.8 ± 0.3 |
A1C (%) | 6.4 ± 0.5 | 6.5 ± 0.3 |
One or more severe hypoglycemia events* in last 6 months | 7 (10) | 7 (11) |
Home glucose meter readings per day† | 7.3 ± 2.4 | 6.8 ± 2.4 |
College graduate (subject or primary care giver) | 58 (87) | 55 (89) |